Lincomycin Injection, Solution
Product Images NDC 25021-193

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lincomycin (NDC 25021-193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Lin0b 0001 01)

Chemical structure of Lincomycin Hydrochloride, showing its molecular connectivity including a methylthio-substituted sugar ring and a proline derivative linked by an amide bond.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Lin0b 0001 02)

Label for Lincomycin Injection, USP 600 mg per 2 mL (300 mg per mL) in a 2 mL multi-dose vial. The label includes NDC 25021-193-02 and states the product is for intramuscular or intravenous use. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.